Key Points
- CEO Jitendra Mohan sold 123,750 shares on April 10 under a pre‑arranged Rule 10b5‑1 plan, generating proceeds of $18,522,900, leaving him with 4,407,982 shares (a 2.73% decrease in ownership).
- Astera Labs reported a Q1 beat with $0.58 EPS vs. $0.51 expected and revenue of $270.6M (up 91.8% YoY), and set Q1 2026 guidance of $0.530–0.540 EPS while the stock recently opened around $170.60.
- Analyst and market sentiment is broadly positive—MarketBeat shows a consensus "Moderate Buy" (15 Buys, 6 Holds, 1 Sell) and rising technical/institutional interest—though some firms (e.g., Citi) trimmed price targets, highlighting mixed near‑term outlook factors.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 123,750 shares of the firm's stock in a transaction on Friday, April 10th. The stock was sold at an average price of $149.68, for a total value of $18,522,900.00. Following the sale, the chief executive officer directly owned 4,407,982 shares of the company's stock, valued at approximately $659,786,745.76. This represents a 2.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jitendra Mohan also recently made the following trade(s):
- On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The stock was sold at an average price of $131.58, for a total value of $20,723,850.00.
- On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51.
Astera Labs Stock Up 2.3%
Shares of NASDAQ ALAB opened at $170.60 on Wednesday. Astera Labs, Inc. has a 12 month low of $52.56 and a 12 month high of $262.90. The company has a market cap of $29.22 billion, a price-to-earnings ratio of 139.84, a P/E/G ratio of 3.28 and a beta of 1.78. The business has a fifty day simple moving average of $128.64 and a 200-day simple moving average of $154.30.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts' expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs's revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of Astera Labs in a report on Wednesday, January 14th. They set an "outperform" rating and a $225.00 price target on the stock. Weiss Ratings cut shares of Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, February 23rd. Citigroup initiated coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They set a "buy" rating and a $200.00 target price on the stock. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Finally, Loop Capital initiated coverage on Astera Labs in a research report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $199.44.
Read Our Latest Research Report on ALAB
Institutional Trading of Astera Labs
Several hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. grew its stake in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Reflection Asset Management purchased a new stake in shares of Astera Labs during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC raised its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank lifted its holdings in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after buying an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs during the 4th quarter valued at about $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Astera Labs News Summary
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Technical momentum: multiple reports highlight a jump in Astera Labs’ relative strength rating (to the high 80s) and rising relative price strength, signaling strong institutional/investor interest that’s boosting the stock. Read More.
- Positive Sentiment: Operational/growth optimism: coverage notes a high double-digit growth outlook and a seven-day winning streak tied to the company’s Q1 beat and optimistic guidance, which is supporting the rally. Read More.
- Positive Sentiment: Fundamental bull case: a long-form bullish piece reiterates a "Strong Buy" view, arguing ALAB is evolving from hardware into a broader platform (COSMOS/Scorpio X roadmap), expanding TAM and multi-product revenue drivers. Read More.
- Positive Sentiment: Institutional/insider interest theme: ALAB appears on lists of top growth stocks with strong insider ownership — a signal some investors use to justify higher conviction in growth names. Read More.
- Neutral Sentiment: Price-action scrutiny: market notes that recent gains occurred on above-average volume but also point out that recent earnings-estimate revisions don’t clearly support continued acceleration — suggesting momentum may need fresh fundamental catalysts to sustain. Read More.
- Neutral Sentiment: Macro headwinds: broader market sensitivity to rising inflation and oil prices could introduce near-term volatility that affects growth/high-beta names like ALAB despite company-specific strength. Read More.
- Negative Sentiment: Analyst target cut: Citi trimmed its price target from $250 to $200 (while keeping a Buy rating), citing AI-related considerations — this reduces some upside and could pressure sentiment if other firms follow. Read More.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
